Dr Preethi Jeyaraman

Clinical Hematologist

Burjeel Medical City

Abu Dhabi, UAE

At the 1st Emirates Hematology Forum, 31 October 2026

Speaker · 16:40–16:55
BRECADD vs. Nivolumab-AVD in Frontline Hodgkin Lymphoma: Which Strategy for Which Patient?
Session: Beyond the Big Three

See the full Forum programme

To correct or remove this profile, write to secretariat@eora.ae.